๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ImageneBio, Inc. (IMA)
NASDAQ: IMA ยท Real-Time Price ยท USD
3.920
-0.060 (-1.51%)
Nov 20, 2026, 4:00 PM EST - Market closed

ImageneBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Revenue
-0.83.57.96
Revenue Growth
--77.14%-56.04%-
Gross Profit
-0.83.57.96
Operating Income
-50.08-48.45-37-21.93
Net Income
-43.33-52.4-48.38-32.04
Earnings Per Share
-3.29-9.64-22.10-0.10
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
126.6135.3512.1225.47
Total Debt
1.312.988.050.98
Net Cash (Debt)
125.29132.374.0724.49
Net Cash Growth
-9.96%3152.43%-83.38%-
Net Cash Per Share
9.5324.371.860.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-40.61-47.84-21.32-18.23
Capital Expenditures
----0.31
Free Cash Flow
-40.61-47.84-21.32-18.54
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Gross Margin
-100.00%100.00%100.00%
Operating Margin
--6056.38%-1057.14%-275.37%
Pretax Margin
--5712.38%-1044.43%-262.09%
Profit Margin
--6549.38%-1382.40%-402.39%
FCF Margin
--5980.50%-609.11%-232.83%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
PS Ratio
-96.44--